Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes.

Alexander Egeberg,Joseph F. Merola,Knut Schäkel,Luis Puig,Patrick D. Mahar,Isabella Yali Wang,Imre Pavo,Christopher Schuster,Christopher E. M. Griffiths

Frontiers in medicine（2022）

引用 2|浏览3

暂无评分

摘要

Despite the higher rate of obesity and extreme obesity in patients with prediabetes and T2D, ixekizumab was an efficacious treatment in treating patients with psoriasis.

查看译文

关键词

ixekizumab,moderate-to-severe psoriasis,obesity,prediabetes,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要